Drugs / Winuf Peri
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02468713 | Jan → Apr 2015 | — | Chonbuk National University Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04259307 | Jan 2020 → Aug 2023 | stroke disorder | Samsung Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Winuf Peri | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04259307 ↗ |
| Route | Intravenous | “infused via peripheral venous catheter” NCT02468713 ↗ |